The popular weight-loss drug Zepbound can now be used to treat sleep apnea  

The FDA on Friday approved Eli Lilly’s weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

 

Related Posts

​A Woman With a Rare Gene Mutation Fights to Avoid Her Mother’s Fate   

America pays significantly more on drugs than its peers, here’s how to fix it  

Bird flu’s rapid spread prompts California to declare a state of emergency